Literature DB >> 9313653

Extraperitoneal laparoscopic dismembered fibrin-glued pyeloplasty: medium-term results.

C G Eden1, S R Sultana, K H Murray, R K Carruthers.   

Abstract

OBJECTIVE: To assess the feasibility and results of performing retroperitoneoscopic dismembered fibrin-glued pyeloplasty in a clinical series of patients with pelvi-ureteric junction (PUJ) obstruction. PATIENTS AND METHODS: A balloon-dissecting four-port extraperitoneal laparoscopic approach was used in each of nine patients (aged 21-60 years) to dismember the PUJ over a previously placed double-pigtail stent, insert stay sutures to appose the urothelium and complete the pelvi-ureteric anastomosis using fibrin glue. Anastomoses were assessed by diuresis renography 3 months after surgery and at yearly intervals thereafter.
RESULTS: Eight of the nine attempted procedures were completed successfully in a median (range) operating time of 180 (150-230) min. The median (range) post-operative parenteral opiate requirement was 0 (0-80) mg morphine sulphate and the post-operative hospitalization was 2 (2-4) nights. A shortened fibrotic ureter prevented the laparoscopic completion of the second case, which was converted to an open procedure. Follow-up imaging after 1-2 years showed satisfactory upper tract drainage in those cases completed successfully. One patient developed a renal pelvic calculus that was treated by extracorporeal shock wave lithotripsy.
CONCLUSION: This technique is associated with a significantly shorter operating time than historical laparoscopic controls, and with a significantly lower post-operative opiate analgesic requirement and shorter post-operative hospitalization than in a contemporaneous series of patients undergoing open pyeloplasty. However, longer term follow-up is needed to fully assess the performance of these anastomoses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313653     DOI: 10.1046/j.1464-410x.1997.00367.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  9 in total

1.  Current Status of Hemostatic Agents and Sealants in Urologic Surgical Practice.

Authors:  Sashi S Kommu; Robert McArthur; Amr M Emara; Utsav D Reddy; Christopher J Anderson; Neil J Barber; Raj A Persad; Christopher G Eden
Journal:  Rev Urol       Date:  2015

2.  Laparoscopic pyeloplasty, initial experience in the management of UPJO.

Authors:  V J Gnanapragasam; T G Armitage
Journal:  Ann R Coll Surg Engl       Date:  2001-09       Impact factor: 1.891

3.  New generation tissue sealants and hemostatic agents: innovative urologic applications.

Authors:  Michael A Traver; Dean G Assimos
Journal:  Rev Urol       Date:  2006

4.  Glue ablation of a late-presentation urinary fistula after partial nephrectomy.

Authors:  J J Aning; M A Stott; A F Watkinson
Journal:  Br J Radiol       Date:  2009-12       Impact factor: 3.039

Review 5.  Fibrin glue applications in urology.

Authors:  U Kumar; D M Albala
Journal:  Curr Urol Rep       Date:  2001-02       Impact factor: 2.862

6.  Use of fibrin glue as a sealant at the anastomotic line in laparoscopic pyeloplasty: A randomised controlled trial.

Authors:  Ahmed Farouk; Ahmed Tawfick; Mohamed Kotb; Alaa Abdellmaksoud; Ahmed Safaan; Mohamed Yassin; Hassan Shaker
Journal:  Arab J Urol       Date:  2016-09-23

Review 7.  Recent advances in urologic surgical techniques for pyeloplasty.

Authors:  Mikolaj Mendrek; Thomas Alexander Vögeli; Christian Bach
Journal:  F1000Res       Date:  2019-03-15

8.  Fibrin glue as a sealant in stentless laparoscopic pyeloplasty: A randomised controlled trial.

Authors:  Ahmed Farouk; Ahmed Tawfick; Mahmoud Reda; Ahmed M Saafan; Waleed Mousa; Ahmed M Tawfeek; Hassan Shaker
Journal:  Arab J Urol       Date:  2019-05-09

9.  Transmesocolic approach for left side laparoscopic pyeloplasty: comparison with laterocolic approach in the initial learning period.

Authors:  Hyun Ho Han; Won Sik Ham; Jang Hwan Kim; Chang Hee Hong; Young Deuk Choi; Sang Won Han; Byung Ha Chung
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.